Biohaven Pharmaceutical Holding Co Ltd (BHVN) — Financial Flexibility Index
Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a Financial Flexibility Index of -0.44x as of March 2026. Free cash flow of $-149.92 Million (operating CF $-149.92 Million minus capex $0.00) represents 0% of total liabilities ($336.91 Million). Also explore Biohaven Pharmaceutical Holding Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biohaven Pharmaceutical Holding Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Biohaven Pharmaceutical Holding Co Ltd across 9 annual periods. Check BHVN capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Biohaven Pharmaceutical Holding Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Biohaven Pharmaceutical Holding Co Ltd. For the full company profile including market capitalisation, see Biohaven Pharmaceutical Holding Co Ltd (BHVN) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.52x | $-608.72 Million | $-609.44 Million | $399.38 Million | ▲ +49.5% |
| 2024 | -3.02x | $-578.40 Million | $-582.45 Million | $191.67 Million | ▲ +21.7% |
| 2023 | -3.86x | $-328.68 Million | $-331.73 Million | $85.24 Million | ▼ -84.8% |
| 2022 | -2.09x | $-256.62 Million | $-297.69 Million | $123.01 Million | ▲ +31.8% |
| 2021 | -3.06x | $-144.90 Million | $-145.84 Million | $47.37 Million | ▼ -45.0% |
| 2020 | -2.11x | $-73.26 Million | $-75.96 Million | $34.72 Million | ▼ -98.0% |
| 2019 | -1.07x | $-374.80 Million | $-377.33 Million | $351.69 Million | ▲ +23.2% |
| 2018 | -1.39x | $-192.98 Million | $-197.14 Million | $139.09 Million | ▲ +78.0% |
| 2017 | -6.32x | $-94.27 Million | $-94.81 Million | $14.92 Million | — |